80 related articles for article (PubMed ID: 19212611)
1. Computer simulations suggest that acute correction of hyperglycaemia with an insulin bolus protocol might be useful in brain FDG PET.
Buchert R; Santer R; Brenner W; Apostolova I; Mester J; Clausen M; Silverman DH
Nuklearmedizin; 2009; 48(1):44-54. PubMed ID: 19212611
[TBL] [Abstract][Full Text] [Related]
2. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
[TBL] [Abstract][Full Text] [Related]
3. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDGPET/CT: diabetes and hyperglycaemia.
Niccoli-Asabella A; Iuele FI; Merenda N; Pisani AR; Notaristefano A; Rubini G
Nucl Med Rev Cent East Eur; 2013; 16(2):57-61. PubMed ID: 24068633
[TBL] [Abstract][Full Text] [Related]
5. Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT.
Pattison DA; MacFarlane LL; Callahan J; Kane EL; Akhurst T; Hicks RJ
EJNMMI Res; 2019 Feb; 9(1):15. PubMed ID: 30737563
[TBL] [Abstract][Full Text] [Related]
6. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
7. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
[TBL] [Abstract][Full Text] [Related]
8. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
9. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
10. An input function estimation method for FDG-PET human brain studies.
Guo H; Renaut RA; Chen K
Nucl Med Biol; 2007 Jul; 34(5):483-92. PubMed ID: 17591548
[TBL] [Abstract][Full Text] [Related]
11. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
12. Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study.
Alf MF; Duarte JM; Schibli R; Gruetter R; Krämer SD
J Nucl Med; 2013 Dec; 54(12):2153-60. PubMed ID: 24159048
[TBL] [Abstract][Full Text] [Related]
13. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
14. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
15. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
[TBL] [Abstract][Full Text] [Related]
17. Computer phantom study of brain PET glucose metabolism imaging using a rotating SPECT/PET camera.
McGoron AJ; Mao X; Georgiou MF; Kuluz JW
Comput Biol Med; 2005 Jul; 35(6):511-31. PubMed ID: 15780862
[TBL] [Abstract][Full Text] [Related]
18. In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device.
Wu HM; Sui G; Lee CC; Prins ML; Ladno W; Lin HD; Yu AS; Phelps ME; Huang SC
J Nucl Med; 2007 May; 48(5):837-45. PubMed ID: 17475972
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
20. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.
Schiffer WK; Mirrione MM; Dewey SL
J Nucl Med; 2007 Feb; 48(2):277-87. PubMed ID: 17268026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
